Strategic Growth Opportunity to partner with a medical device innovator focused on catheter-based ablation for atrial fibrillation, leveraging DiamondTemp technology which could attract larger strategic buyers or co-development deals with major electrophysiology players.

Acquisition Readiness Historical interest from larger medtechs (Medtronic acquisition of ActMed) plus a substantial funding runway suggest a potential for strategic investment, license deals, or acquisition discussions as the DiamondTemp system progresses through regulatory and IDE milestones.

Regulatory Pathways DiamondTemp system has CE Mark and IDE activity; potential sales opportunities in regions where regulatory approvals are proceeding, and collaboration with distributors or regional partners to accelerate adoption in AFIB ablation workflows.

Market Expansion AFIB catheter ablation market is fast-growing with sizable patient population; targeting hospitals and high-volume electrophysiology labs, plus pain points around irrigation flow, temperature feedback, and high-resolution attenuation can drive demand for next-gen systems.

Funding & Collaboration Strong funding history ($69M total) and prior equity rounds indicate appetite for collaboration; explore co-development, joint ventures, or performance-based commercialization deals to broaden market reach and accelerate reimbursement discussions.